Furthermore, the significant effect of CDKN1A haplotypes on its’ gene expression in both RRMS and SPMS suggests that certain molecular processes may be relevant in both phases of MS, consistent with the recently adopted concept that further research needs to perceive this complex disease as a continuum, beyond common stratification by disease course [3]. Here, CDKN1A is linked to myeloid sarcoma.